Table 2:
Total number of patients who completed HSCT | 350 |
Age (median) | 54 (range 8-75) |
Sex (male/female) | 207 (59.1%) / 143 (40.9%) |
Primary disease - Multiple Myeloma - Non-Hodgkin’s Lymphoma - Hodgkin’s Lymphoma - Leukemia - Other |
104 (29.7%) 99 (28.3%) 28 (8.0%) 95 (27.1%) 24 (6.9%) |
Transplant type - Allogeneic - Autoloaous |
143 (40.9%) 207 (59.1%) |
(HSCT: Hematopoietic stem cell transplant)